CANTI, GIANFRANCO
 Distribuzione geografica
Continente #
EU - Europa 4.811
NA - Nord America 2.495
AS - Asia 1.275
SA - Sud America 29
OC - Oceania 8
AF - Africa 6
Totale 8.624
Nazione #
US - Stati Uniti d'America 2.480
GB - Regno Unito 2.130
SE - Svezia 851
CN - Cina 539
IT - Italia 512
DE - Germania 366
TR - Turchia 273
KR - Corea 202
IE - Irlanda 172
UA - Ucraina 168
RU - Federazione Russa 144
FI - Finlandia 120
FR - Francia 117
IN - India 107
NL - Olanda 106
EU - Europa 101
VN - Vietnam 84
GR - Grecia 33
BE - Belgio 30
HK - Hong Kong 19
PL - Polonia 17
CO - Colombia 16
DK - Danimarca 14
ID - Indonesia 14
SG - Singapore 14
CA - Canada 9
ES - Italia 8
BR - Brasile 7
NO - Norvegia 7
CH - Svizzera 6
MX - Messico 6
JP - Giappone 5
AU - Australia 4
CL - Cile 4
EG - Egitto 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
RO - Romania 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
MY - Malesia 2
PH - Filippine 2
AR - Argentina 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GE - Georgia 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 8.725
Città #
Southend 1.884
Seattle 342
Chandler 295
Milan 219
Princeton 209
Wilmington 192
Dublin 172
Hanover 137
Redmond 136
Ann Arbor 115
Mountain View 105
Sakarya 98
Beijing 95
Des Moines 80
Ashburn 78
Nanjing 77
Fairfield 75
Woodbridge 66
Jacksonville 62
Frankfurt am Main 60
Boardman 59
Bengaluru 52
Dearborn 46
Eitensheim 46
Dong Ket 44
Jinan 44
Houston 38
Shenyang 36
Athens 33
Brussels 28
Serra 28
Hebei 26
Changsha 24
Zhengzhou 24
Nanchang 21
Guangzhou 20
Shanghai 20
Andover 19
Helsinki 19
New York 19
Bitonto 18
Cambridge 17
Falls Church 17
Los Angeles 17
Phoenix 15
Somerville 15
Tianjin 15
Bogotá 14
Ningbo 14
Warsaw 14
Redwood City 13
San Diego 13
San Martino Siccomario 13
Hefei 12
Hong Kong 12
Fremont 11
Seoul 11
Jiaxing 10
Sunnyvale 10
Auburn Hills 8
Kunming 8
Medford 8
Berlin 7
Roxbury 7
Taizhou 7
Turin 7
Chengdu 6
Collegno 5
Gessate 5
Guilford 5
Haikou 5
Hangzhou 5
Lafayette 5
Lakewood 5
Lanzhou 5
Norwalk 5
Odernheim 5
Toronto 5
Washington 5
Fuzhou 4
Istanbul 4
London 4
Offanengo 4
Pisa 4
Singapore 4
São Paulo 4
Taipei 4
Tappahannock 4
Trondheim 4
Verona 4
Xian 4
Bologna 3
Como 3
Edinburgh 3
Marcy 3
Mumbai 3
Ottawa 3
Saint Petersburg 3
Silver Spring 3
Wokingham 3
Totale 5.597
Nome #
Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells 252
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 248
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity 193
Computational modeling of the metabolic states regulated by the kinase Akt 161
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt 145
Inhibition of tumor cell proliferation by linear polyunsaturated aldehydes 140
Assimilation of LDL by experimental tumours in mice 140
Terapia fotodinamica e nuovi fotosensibilizzanti 135
Fotoimmunologia. In Fotodermatologia 134
Antitumor activity of photodynamic therapy, adoptive immunotherapy, and chemotherapy in experimental tumor 132
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light 129
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger 128
[The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine)] 128
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia 122
Alterazioni antigeniche indotte da dimetil-triazeno-carbossamide (DTIC) nella leucemia L1210. Attivita' citotossica in vitro di splenociti immuni. 121
Action spectrum of photoactivated phthalocyanine AIS2Pc in tumor bearing mice 118
Increased bcl2 expression by antisense oligoribonucleotides targeting the adenine-uridine-rich element motif 116
Systems biology of the metabolic network regulated by the Akt pathway 115
2-[125i]iodomelatonin binding in normal and neoplastic tissues 113
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines 112
Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors 110
Stabilization of cellular mRNAs and up-regulation of proteins by oligoribonucleotides homologous to the Bcl2 adenine-uridine rich element motif 109
Immunopharmacology studies on photosensitizers used in photodynamic therapy (PDT) 109
Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia 108
Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of guinea pig hepatoma 107
Low doses of cisplatin or gemcitabine plus photofrin/photodynamic therapy : disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299) 106
Preferential chemosensitization of PTEN-mutated prostate cells by silencing the Akt kinase 102
DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity 102
In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays 102
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles 99
Toxicity of fenclor 42 in mice: effects on immunocompetent cells 99
Haematoporphyrin-treated murine lymphocytes: in vitro inhibition of DNA synthesis and light-mediated inactivation of cells responsible for GVHR 99
Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210) 96
Decay time images of HpD fluorescence for tumor detection in mice 95
Hematoporphyrin derivative photoradiation therapy in murine solid tumors 95
Adoptive immunity in mice challenged with L1210/DTIC clones 94
Effect of photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine on antitumor immune response 94
Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors 92
Use of time-gated fluorescence imaging for diagnosis in biomedicine 91
L1210/DTIC antigenic subline: studies at the clone level 90
Oligonucleotide degradation contributes to resistance to antisense compounds 90
In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice 90
Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy 89
Immunological cross-reactivity between H-2Dk product and DTIC-treated H-2d lymphoma 89
Humoral and cellular immunoresponse of mice treated with pyrazole-carboxamide-4-amino (PCA). 89
[Possible applications of living BCG and the BCG cell wall in immunotherapy] 88
Laser oncology in Italy: experimental research and clinical applications at the National Cancer Institute, Milan 88
Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines 87
B16 melanoma response in vivo to photochemotherapy with mitoxantrone and red light 86
Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG) 86
Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody 86
Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells 85
Comparative study of the therapeutic effect of photoactivated hematoporphyrin derivative and aluminum disulfonated phthalocyanines on tumor bearing mice 85
Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect 85
Monoclonal antibody to L1210 leukemia: characterization and therapeutic activity 85
Effect of the tiapamil analog RO11-2933 on cellular sensitivity to antitumor drugs in sensitive and multidrug resistant human ovarian cancer cells 83
Tumor detection in mice by measurement of fluorescence decay time matrices 83
Induction of new antigenic properties on DTIC-treated L1210 clones 82
Photodynamic therapy in vitro and in vivo with hematoporphyrin derivative and laser light 78
Regression of established oral tumors after intralesional injection of living BCG or BCG cell walls 78
Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells 77
Study of porphyrin fluorescence in tissue samples of tumour-bearing mice 77
Photoradiation therapy with Hpd and laser light 77
Fluorescence molecular tomography of an animal model using structured light rotating view acquisition 74
Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin 73
Absorption spectrum of hematoporphyrin derivative in vivo in a murine tumor model 73
Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery 72
Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line 72
Study on the absorption properties of sulphonated aluminum phthalocyanine in vivo and ex vivo in murine tumor models 71
Time-gated fluorescence imaging of different organs in tumor-bearing mice after porphyrin administration 71
Tumour visualization in a murine model by time-delayed fluorescence of sulphonated aluminium phthalocyanine 71
Absorption spectra of photosensitizers detected in vivo in tumor bearing mice 70
Time-gated fluorescence spectroscopy of porphyrin derivatives and aluminium phthalocyanine incorporated in vivo in a murine ascitic tumour model 70
PLASMA RETINOL LEVELS AND SIDE-EFFECTS FOLLOWING HIGH-DOSE RETINYL ACETATE IN BREAST-CANCER PATIENTS 68
Fluorescence molecular tomography on animal model by means of multiple views structured light illumination 67
delta-Aminolevulinic acid induced fluorescence in tumour-bearing mice 66
Antitumor therapeutic efficacy of photoactivated phthalocyanines ZnS4Pc and AlS2Pc in tumor bearing mice 66
Investigation of the system copper(II) carbonic anhydrase and HCO3-/CO2 65
Multispectral and lifetime imaging for the detection of skin tumors 65
Immunocytochemical staining of serous effusions 63
Time-resolved fluorescence spectroscopy of hematoporphyrin derivatives and disulfonated aluminum phthalocyanine incorporated in vivo in a murine ascitic tumor 63
Time-gated fluorescence imaging for the diagnosis of tumors in different murine models 62
Chemioterapici antitumorali: Alchilanti 62
In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model 61
Photodynamic therapy in experimental oncology with porphyrins and phthalocyanines 60
Time-gated fluorescence imaging for the diagnosis of tumors in a murine model 60
Two-step photoactivation of porphyrins with nanosecond red pulses 59
Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933 58
Time-gated fluorescence spectroscopy and imaging of porphyrins and phthalocyanines 58
In-vivo incorporation of photosensitizing drugs in a murine ascitic tumor 58
Photodynamic therapy with photoactivated aluminum disulfonated phthalocyanine and cellular immune response 57
Time-gated fluorescence spectroscopy of porphyrin derivatives incorporated into cells 57
Photodynamic therapy and immune response in tumor-bearing mice 57
Fluorescence lifetime imaging of experimental tumors in hematoporphyrin derivative-sensitized mice 56
Fluorescence imaging during photodynamic therapy of experimental tumors in mice sensitized with disulfonated aluminum phthalocyanine 56
Time-gated fluorescence spectroscopy of hematoporphyrin derivative incorporated in L1210 cells 56
Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice 54
Immunofarmacologia dei nuovi composti fotosensibilizzanti nella PDT dei tumori 54
STUDIES OF THE EFFECT OF 2 PORPHYRINS ON THE LYMPHOHEMATOPOIETIC SYSTEM IN IRRADIATED MICE 53
Photodiagnosis of tumors 51
Totale 9.153
Categoria #
all - tutte 20.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 18 32 38
2019/2020898 161 9 55 42 46 76 64 41 181 170 39 14
2020/20211.344 180 34 145 9 154 47 46 40 153 59 364 113
2021/20221.068 98 41 35 88 102 85 65 61 46 107 131 209
2022/20231.315 174 148 120 156 149 308 17 79 95 12 39 18
2023/2024474 18 70 43 17 129 21 23 45 29 79 0 0
Totale 9.292